1 Year Total Returns (Daily) Chart

View 1 Year Total Returns (Daily) for ACTU.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View 1 Year Total Returns (Daily) Chart
Start Trial

Historical 1 Year Total Returns (Daily) Data

View and export this data back to 2025. Start Trial.
Date Value
September 18, 2026 -85.71%
September 17, 2026 -85.62%
September 16, 2026 -85.83%
September 15, 2026 -85.95%
September 14, 2026 -84.56%
September 11, 2026 -84.63%
September 10, 2026 -83.28%
September 09, 2026 -85.19%
September 08, 2026 -82.75%
September 04, 2026 -83.03%
September 03, 2026 -84.09%
September 02, 2026 -85.06%
September 01, 2026 -81.75%
August 31, 2026 -81.99%
August 28, 2026 -79.87%
August 27, 2026 -79.01%
August 26, 2026 -78.27%
August 25, 2026 -80.20%
August 24, 2026 -85.29%
August 21, 2026 -83.43%
August 20, 2026 -83.97%
August 19, 2026 -86.70%
August 18, 2026 -87.27%
August 17, 2026 -87.81%
August 14, 2026 -87.71%
Date Value
August 13, 2026 -88.57%
August 12, 2026 -88.81%
August 11, 2026 -87.39%
August 10, 2026 -87.28%
August 07, 2026 -86.31%
August 06, 2026 -84.94%
August 05, 2026 -84.54%
August 04, 2026 -84.16%
August 03, 2026 -85.40%
July 31, 2026 -84.69%
July 30, 2026 -83.91%
July 29, 2026 -84.05%
July 28, 2026 -84.55%
July 27, 2026 -84.16%
July 24, 2026 -83.12%
July 23, 2026 -80.91%
July 22, 2026 -79.79%
July 21, 2026 -76.15%
July 20, 2026 -75.69%
July 17, 2026 -77.00%
July 16, 2026 -73.35%
July 15, 2026 -71.19%
July 14, 2026 -72.10%
July 13, 2026 -75.57%
July 10, 2026 -80.42%

Total Return Definition

The Total return is the change in price over a specific period of time that includes dividends and distributions paid.

Read full definition.

1 Year Total Returns (Daily) Range, Past 5 Years

View 1 Year Total Returns (Daily) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

1 Year Total Returns (Daily) Benchmarks

View 1 Year Total Returns (Daily) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 10.24%
Alnylam Pharmaceuticals, Inc. -47.02%
Anika Therapeutics, Inc. 132.8%
Savara, Inc. 49.17%
Vericel Corp. 25.65%